Thursday, 23 June 2022

Researchers develop blood test to predict liver cancer risk

Researchers develop blood test to predict liver cancer risk
researchers develop blood test to predict liver cancer risk

An estimated one-quarter of adults in the U.S. have nonalcoholic fatty liver disease (NAFLD), an excess of fat in liver cells that can cause chronic inflammation and liver damage, increasing the risk of liver cancer. Now, UT Southwestern researchers have developed a simple blood test to predict which NAFLD patients are most likely to develop liver cancer.

admin Thu, 06/23/2022 - 15:50

source https://www.pharmatutor.org/pharma-news/2022/researchers-develop-blood-test-to-predict-liver-cancer-risk

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...